Загрузка...
Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Background and objectives: Ongoing randomized trials seek to validate the efficacy of rituximab as an induction agent for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). However, no studies directly address the role of rituximab as maintenance therapy. Design, setting, parti...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Nephrology
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2924418/ https://ncbi.nlm.nih.gov/pubmed/20498238 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.08821209 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|